High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer
- 12 October 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 32 (11) , 2209-2217
Abstract
Does high gonadotropin dosage affect euploidy and pregnancy rates in PGS cycles with single embryo transfer? High gonadotropin dosage does NOT affect euploidy and pregnancy rates in PGS cycles with single embryo transfer. PGS has been proven to be the most effective and reliable method for embryo selection in IVF cycles. Euploidy and blastulation rates decrease significantly with advancing maternal age. In order to recruit an adequate number of follicles, the average dosage of gonadotropins administered during controlled ovarian stimulation in IVF cycles often increases significantly with advancing maternal age. A retrospective study of SNP (Single Nucleotide Polymorphism) PGS outcome data from blastocysts biopsied on day 5 or day 6 was conducted to identify differences in euploidy and clinical pregnancy rates. Seven hundred and ninety four cycles of IVF treatment with PGS between January 2013 and January 2017 followed by 651 frozen embryo transfers were included in the study (506 patients, maternal age (y.o.) – 37.2 ± 4.31). A total of 4034 embryos were analyzed (5.1 ± 3.76 per case) for euploidy status. All embryos were vitrified after biopsy, and selected embryos were subsequently thawed for a hormone replacement frozen embryo transfer cycle. All cycles were analyzed by total gonadotropin dosage (5000 IU), by number of eggs retrieved (1–5, 5–10, 10–15 and >15 eggs) and patient's age (P = 0.2) and from 69.5% (1–5 eggs retrieved) to 60.0% (>15 eggs retrieved) (OR = 0.658, 95% CI 0.405–1.071, P = 0.09). Similar data were obtained in the oldest group of patients (≥41 y.o. – 189 IVF cycles): euploidy rates ranged from 30.7 to 26.4% (OR = 0.811, 95% CI 0.452–1.454, P = 0.481) when analyzed by total dosage of gonadotropins used in the IVF cycle and from 40.0 to 30.7% (OR = 0.531, 95% CI 0.204–1.384, P = 0.19), when assessed by the total number of eggs retrieved. Ongoing pregnancy rates were similar, not only within particular age groups, but also between different age groups regardless of the total dosage of gonadotropins used: ranging from to 63.6% (5000 IU, ≥41 y.o) (OR = 0.696, 95% CI 0.310–1.565, P = 0.38). Retrospective study and heterogeneity of patients included. These data are reassuring for the common practice of increasing gonadotropin dosages in PGS cycles, particularly in older woman. No formal funding has been received for this study. N/A.Keywords
This publication has 29 references indexed in Scilit:
- The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in ChinaHuman Reproduction, 2013
- Array CGH analysis shows that aneuploidy is not related to the number of embryos generatedReproductive BioMedicine Online, 2012
- What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rateHuman Reproduction, 2009
- Cryopreservation of supernumerary high quality embryos predicts favorable outcomes for patients undergoing repeated cycles of in vitro fertilizationFertility and Sterility, 2008
- Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trialHuman Reproduction, 2007
- In vitro fertilization (IVF) in Sweden: Risk for congenital malformations after different IVF methodsBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Meiotic and mitotic nondisjunction: lessons from preimplantation genetic diagnosisHuman Reproduction Update, 2004
- Evaluation of developmental competence, nuclear and ooplasmic maturation of calf oocytesMolecular Reproduction and Development, 1996
- Gonadotropin stimulation regimens for follicular aspiration and in vitro embryo production from calf oocytesTheriogenology, 1994
- Incidence of nondisjunction in mouse oocytesCytogenetic and Genome Research, 1979